Document:

EX-10.1

 Exhibit 10.1 

QUOTIENT LIMITED 

CHANGE OF CONTROL AGREEMENT 

THIS CHANGE OF CONTROL AGREEMENT (this “Agreement”), is made on this 20 day of November 2020, by and between QUOTIENT
LIMITED, a public no par value limited liability company incorporated in Jersey, Channel Islands, with registered number 109886 (the “Company”) and Franz Walt (the “Employee”). 

WHEREAS, the Employee serves as an employee of the Company or an Affiliate of the Company; and 

WHEREAS, the Company and the Employee desire to enter into this Agreement to establish certain protections for the Employee in the event of
Employee’s termination of employment under the circumstances described herein; and 
 NOW, THEREFORE, in consideration of the foregoing
and the mutual covenants and promises contained herein, and intending to be bound hereby, the parties agree as follows: 
 Section 1.
Definitions. As used herein: 
 1.1 “Affiliate” means, with respect to any specified Person, any other Person that
directly or indirectly, through one or more intermediaries, Controls, is Controlled by, or is under common Control with, such specified Person, provided that, in any event, any business in which the Company has any direct ownership interest shall be
treated as an Affiliate of the Company. 
 1.2 “Base Salary” means, as of any given date, the annual base rate of salary
payable to the Employee by the Company; provided, however, that in the case of a resignation by the Employee for the Good Reason described in Section 1.8, “Base Salary” will mean the annual base rate of salary
payable to the Employee by the Company as in effect immediately prior to the reduction giving rise to the Good Reason. 
 1.3
“Board” means the Board of Directors of the Company. 
 1.4 “Cause” means (a) gross negligence or
willful misconduct by the Employee in the performance of his duties; (b) conviction of or a plea of nolo contendere by the Employee of a felony or act of moral turpitude (or similar local law concepts); or (c) the Employee’s
fraud, embezzlement or misappropriation relating to material amounts of the Company’s assets. The acts or omissions of the Employee shall not be considered to be willful unless he has no reasonable belief that he is acting in the best interests
of the Company. 
 1.5 “Change of Control” means: 

1.5.1 The acquisition, directly or indirectly, in one transaction or a series of related transactions, by any person or group (within the
meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) of the beneficial ownership of securities of the Company possessing more than fifty percent (50%) of the total combined voting power of all outstanding securities
of the Company; provided, however, that a Change in Control shall not result upon such acquisition of beneficial ownership if such acquisition occurs as a result of a public offering of the Company’s securities or any financing transaction or
series of financing transactions; 
 1.5.2 A merger or consolidation in which the Company is not the surviving entity, except for a
transaction in which the holders of the outstanding voting securities of the Company immediately prior to such merger or consolidation hold as a result of holding Company securities prior to such transaction, in the aggregate and in the same
proportions, securities possessing more than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the surviving entity (or the parent of the surviving entity) immediately after such merger or consolidation;

 1.5.3 A reverse merger in which the Company is the surviving entity but in which the holders of the outstanding voting securities of the
Company immediately prior to such merger hold, in the aggregate securities possessing less than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the Company or of the acquiring entity immediately after
such merger; or 
 1.5.4 The sale, transfer or other disposition (in one transaction or a series of related transactions) of all or
substantially all of the assets of the Company, except for a transaction in which the holders of the outstanding voting securities of the Company immediately prior to such transaction(s) receive as a distribution with respect to securities of the
Company, in the aggregate, securities possessing more than fifty percent (50%) of the total combined voting power of all outstanding voting securities of the acquiring entity immediately after such transaction(s). 

 1.6 “Control” (including, with correlative meanings, the terms
“Controlled by” and “under common Control with”), as used with respect to any Person, means the direct or indirect possession of the power to direct or cause the direction of the management or policies of such
Person, whether through the ownership of voting securities, by contract or otherwise. 
 1.7 “Disability” means a condition
entitling the Employee to benefits under the Company’s long term disability plan, policy or arrangement; provided, however, that if no such plan, policy or arrangement is then maintained by the Company and applicable to the
Employee, “Disability” will mean the Employee’s inability, by reason of any physical or mental impairment, to substantially perform Employee’s regular duties to the Company, as determined by the Board in its sole discretion
(after affording the Employee the opportunity to present Employee’s case), which inability is reasonably contemplated to continue for at least one year from its commencement and at least 90 days from the date of such determination. 

1.8 “Equity Award” any share option, restricted share unit or other equity-based award originally issued by the Company to
the Employee prior to the date of a Change of Control (including any replacement equity- based award issued in exchange therefor on or after the date of a Change of Control). 

1.9 “Good Reason” means the occurrence of any of the following events, without the Employee’s written consent, unless
such events are fully corrected in all material respects by the Company within thirty (30) days following written notification by the Employee to the Company of the occurrence of one of the reasons set forth below: 

1.9.1 A reduction in the Employee’s rate of the Base Salary; 

1.9.2 A material diminution in the Employee’s titles, authority or duties, including, without limitation, ceasing to be a chief executive
officer who reports directly to the board of directors of a public company; or 
 1.9.3 The Company’s relocation of the Employee’s
principal place of employment to a location more than fifty (50) miles from the Employees current principal place of employment. 
 In
order to terminate for Good Reason, the Employee must provide the Company with written notice describing the event(s) alleged to constitute Good Reason within sixty (60) days after first becoming aware of the occurrence of such event(s), and
the Company will have thirty (30) days to cure such event(s) following receipt of such written notice. If such event(s) are not so cured, the Employee must actually provide the Company with written notice of Employee’s termination of
employment for Good Reason within thirty (30) days following the expiration of the Company’s cure period and thereafter Employee must terminate employment immediately following the completion of the applicable notice period. Otherwise, any
claim of such circumstances as “Good Reason” will be deemed irrevocably waived by the Employee. 
 1.10 “Person”
means any individual, firm, corporation, partnership, limited liability company, trust, joint venture, association, governmental entity, unincorporated entity or other entity. 

1.11 “Release” means a release substantially identical to the one attached hereto as Exhibit A. 

Section 2. Certain Terminations. 

2.1 Severance Events Following a Change of Control. If the Employee’s employment with the Company ceases within the twenty four
(24) month period following the date of a Change of Control as a result of a termination by the Company without Cause or a resignation by the Employee for Good Reason, then the Employee will be entitled to a lump sum payment of the following:

 2.1.1 (i) any Base Salary earned through the effective date of termination that remains unpaid, with any such amounts paid on the first
regularly scheduled payroll date following the effective date of termination; (ii) any bonus payable with respect to any fiscal year which ended prior to the effective date of the Employee’s termination of employment, which remains unpaid,
with such amount paid in the first regularly scheduled payroll date following the effective date of termination or, if later, at the same time the bonus would have otherwise been payable to the Employee; and (iii) any expense reimbursement due
to the Employee on or prior to the date of such termination which remains unpaid to the Employee, with any such reimbursement being made promptly following the effective date of termination (collectively, the “Accrued Obligations”);
and 

 2.1.2 a cash payment equal to 200% of the sum of the Employee’s Base Salary plus target
annual bonus in effect on the date of termination (without taking into effect any reduction described in Section 1.8.1 above). 
 In
addition, immediately prior to the effective date of termination, 100% of the Employee’s then outstanding, unvested Equity Awards will immediately vest and, if applicable, become exercisable (and any rights of repurchase by the Company or
restriction on sale on the Employee’s then outstanding Equity Awards will lapse), and, following the effective date of termination, the Employee’s then outstanding Equity Awards will, if applicable, remain exercisable for a period of 12
months or until the expiration date of the Equity Award, whichever is the shorter period. 
 Except as otherwise provided in this
Section 2, the Company will have no further liability or obligation by reason of such cessation of employment. The payment described in this Section 2 is in lieu of (and not in addition to) any other severance plan, fund, agreement or
other similar arrangement maintained by the Company, including, pursuant to any employment or services agreement between the Company or an Affiliate thereof and the Employee. Notwithstanding any provision of this Agreement, the payment described in
Section 2.1.2 is conditioned on the Employee’s execution and delivery to the Company of the Release within the period beginning on the first day of the second calendar month immediately following Employee’s termination of employment
and ending on the last day of such calendar month. The payment described in Section 2.1.2 will be made one month after receipt by the Company of the Release. On and after a Change in Control, subject to the applicable notice period, the Company
may terminate Employee without Cause or the Employee may resign for Good Reason in accordance with the provisions of Section 1.8 above. 

2.2 Other Terminations. If the Employee’s employment with the Company ceases for any reason other than as described in
Section 2.1 (including but not limited to (a) termination by the Company for Cause, (b) resignation by the Employee without Good Reason, (c) termination as a result of the Employee’s Disability, or (d) the Employee’s
death), then the Company’s obligation to the Employee will be limited solely to the payment of The Accrued Obligations, and the Employee’s then outstanding Equity Awards will be treated in accordance with the terms of the applicable award
agreements. All compensation and benefits will cease at the time of such cessation of employment and, except as otherwise provided by applicable law, the Company will have no further liability or obligation by reason of such termination. 

2.3 Social Security. Any social security payments legally due in connection with this Agreement with the Employee will be paid by the
Company. 
 Section 3. Miscellaneous. 

3.1 Successors and Assigns. This Agreement shall inure to the benefit of and be binding upon the Company and Employee and their
respective successors, executors, administrators, heirs and/or permitted assigns; provided, however, that neither Employee nor the Company may make any assignments of this Agreement or any interest herein, by operation of law or
otherwise, without the prior written consent of the other party, except that, without such consent, the Company may assign this Agreement to any successor to all or substantially all of its assets and business by means of liquidation, dissolution,
merger, consolidation, transfer of assets, or otherwise. 
 3.2 Governing Law. This Agreement shall be governed by and construed
under and according to the laws of Switzerland without regard to its conflict of laws provisions. 
 3.3 Waivers; Separability. The
waiver by either party hereto of any right hereunder or any failure to perform or breach by the other party hereto shall not be deemed a waiver of any other right hereunder or any other failure or breach by the other party hereto, whether of the
same or a similar nature or otherwise. No waiver shall be deemed to have occurred unless set forth in a writing executed by or on behalf of the waiving party. No such written waiver shall be deemed a continuing waiver unless specifically stated
therein, and each such waiver shall operate only as to the specific term or condition waived. Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any
provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability will not affect any other provision or the effectiveness
or validity of any provision in any other jurisdiction, and this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provision had never been contained herein. 

 3.4 Notices. All notices and communications that are required or permitted to be
given hereunder shall be in writing and shall be deemed to have been duly given when delivered personally or upon mailing by registered or certified mail, postage prepaid, return receipt requested, as follows: 

If to the Company, to: 

Quotient Limited 

PO Box 1075 - JTC House 

28 Esplanade 

St Helier 

Jersey JE4 2QP 

Channel Islands  

Attn: Chairman 

If to Employee, to the address on file with the Company, or to such other address as may be specified in a notice given by one party to the
other party hereunder. 
 3.5 Entire Agreement; Amendments. This Agreement contains the entire agreement and understanding of the
parties relating to the provision of severance benefits upon termination in connection with a Change of Control, and merges and supersedes all prior and contemporaneous discussions, agreements and understandings of every nature relating to that
subject. 
 3.6 Withholding. The Company will withhold from any payments due to Employee hereunder, all taxes or other amounts
required to be withheld pursuant to any applicable law. 
 3.7 Headings Descriptive. The headings of sections and paragraphs of this
Agreement are inserted for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement. 

3.8 Counterparts and Facsimiles. This Agreement may be executed, including execution by electronic or facsimile signature, in one or
more counterparts, each of which shall be deemed an original, and all of which together shall be deemed to be one and the same instrument. 

3.9 Term of Agreement. This Agreement shall expire, and the Employee will have no rights hereunder, on November 20, 2023 or on each
anniversary thereof if and only if the Board provides written notice to the Employee of such expiration at least 90 days prior to November 20, 2023 or the applicable anniversary thereof; provided, however, that, notwithstanding the foregoing, the
Board shall not be authorized to cause this Agreement to expire, and this Agreement shall not expire, on or after the date of a Change in Control. Notwithstanding anything in this Agreement to the contrary, if this Agreement is in effect immediately
prior to a Change in Control, thereafter this Agreement shall remain in effect for not less than two years following the date of such Change in Control. 

[signature page follows] 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date and year
first above written. 
  

			
	QUOTIENT LIMITED
		
	By:	 	 /s/ Heino von Prondzynski

		 	Heino von Prondzynski
		 	Chairman

  

	
	 /s/ Franz Walt

	Franz Walt

 EXHIBIT A 

RELEASE AND WAIVER OF CLAIMS 

This Release and Waiver of Claims (“Release”) is entered into as of this [●] day of [●], 20[●], between
QUOTIENT LIMITED and any successor thereto (collectively, the “Company”) and [●] (the “Executive”). 

The Executive and the Company agree as follows: 
  

	 	1.	 The employment relationship between the Executive and the Company, or an affiliate of the Company, was
terminated on [●] (the “Termination Date”). 

 2.    In accordance with the change of control
agreement, dated [●], between the Executive and the Company, as it may be amended from time to time (the “Change of Control Agreement”), the Executive is entitled to receive certain payments and benefits after the Termination
Date. 
 3.    In consideration of the above, the sufficiency of which the Executive hereby acknowledges, the Executive, on behalf of
the Executive and the Executive’s heirs, executors and assigns, hereby releases and forever discharges the Company and its shareholders, parents, affiliates, subsidiaries, divisions, any and all of its or their current and former directors,
officers, employees, agents, and contractors and their heirs and assigns, and any and all employee pension benefit or welfare benefit plans of the Company, including current and former trustees and administrators of such employee pension benefit and
welfare benefit plans (the “Released Parties”), from all claims, charges, or demands, in law or in equity, whether known or unknown, which may have existed or which may now exist from the beginning of time to the date of this
Release, including, without limitation, any claims the Executive may have arising from or relating to the Executive’s employment or termination from employment with the Company and its affiliates. 

4.    The Executive acknowledges that the consideration given for this Release is in addition to anything of value to which the Executive
is already entitled. If the Executive has not returned the signed Release within the time permitted under the Change of Control Agreement, then the offer of payment set forth in the Change of Control Agreement will expire by its own terms at such
time. 
 5.    This Release does not release the Released Parties from (i) any obligations due to the Executive under the Change of
Control Agreement, or under this Release, (ii) any vested rights the Executive has under the Company’s employee benefit plans in which the Executive participated, (iii) any rights or claims that arise from actions or omissions after
the date of execution by the Executive of this Release, (iv) any rights that cannot be waived as a matter of applicable law, or (v) any rights to indemnification the Executive may have under any indemnity agreement, applicable law, the
by-laws, certificate of incorporation, or other constituent document of the Company or any of its affiliates or as an insured under any director’s and officer’s liability insurance policy now or previously in force. 

6.    This Release is not an admission by the Released Parties of any wrongdoing, liability or violation of law. 

7.    The Executive waives any right to reinstatement or future employment with the Company following the Executive’s separation from
the Company. 
 8.    This Release shall be governed by and construed in accordance with the laws of the Switzerland, without regard to
conflicts or laws principles thereof. 
 9.    This Release and the Change of Control Agreement represent the complete agreement between
the Executive and the Company concerning the subject matter in this Release and supersedes all prior agreements or understandings, written or oral. This Release may not be amended or modified otherwise than by a written agreement executed by the
parties hereto or their respective successors and legal representatives. 
 10.    Each of the sections contained in this Release shall
be enforceable independently of every other section in this Release, and the invalidity or unenforceability of any section shall not invalidate or render unenforceable any other section contained in this Release. 

11.    The Executive acknowledges that the Executive has carefully read and understands this Release, that the Executive has the right
to consult an attorney with respect to its provisions and that this Release has been entered into voluntarily. The Executive acknowledges that no representation, statement, promise, inducement, threat or suggestion has been made by any of the
Released Parties to influence the Executive to sign this Release except such statements as are expressly set forth herein or in the Change of Control Agreement. 

[The remainder of this page intentionally left blank.] 

 The parties to this Release have executed this Release as of the day and year first written
above. 
  

					
	QUOTIENT LIMITED
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

  

	
	              

	[Executive]Exhibit 4.4

 

DESCRIPTION OF THE REGISTRANT’S SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

 

The following description of the securities
of Oramed Pharmaceuticals Inc. (the “Company”) is a summary only. This summary is not complete and is subject to and
qualified by the provisions of the Company’s Certificate of Incorporation, as amended (the “Charter”), and Amended
and Restated By-laws, as amended (the “By-laws”), which are filed as exhibits to the Company’s Annual Report
on Form 10-K for the fiscal year ended August 31, 2020 and are incorporated by reference herein.

 

Common Stock

 

Pursuant to the Company’s Charter,
the Company is authorized to issue up to sixty million (60,000,000) shares of common stock, par value $0.012 per share (the “Common
Stock”).

 

The Common Stock is traded on The Nasdaq
Capital Market and the Tel Aviv Stock Exchange, in each case under the symbol “ORMP”.

 

The holders of shares of Common Stock vote
together as one class on all matters as to which holders of Common Stock are entitled to vote. Except as otherwise required by
applicable law, all voting rights are vested in and exercised by the holders of Common Stock with each share of Common Stock being
entitled to one vote, including in all elections of directors. The Company does not have a classified board of directors (the “Board”).

 

The holders of Common Stock are entitled
to receive ratably such dividends, if any, as may be declared from time to time by the Board out of legally available funds therefore.
The Company has not declared any dividends on its Common Stock and does not anticipate paying any dividends on its Common Stock
in the foreseeable future.

 

In the event of the Company’s liquidation,
dissolution or winding up, holders of the Common Stock are entitled to share ratably in all assets remaining after payment of liabilities.
The Common Stock has no cumulative voting rights and no preemptive or other rights to subscribe for shares of the Company.

 

There are no redemption or sinking fund
provisions applicable to the Common Stock. All shares of Common Stock currently outstanding are fully paid and non-assessable.

 

The Company is permitted to issue, and
has from time to time, issued warrants and options to purchase shares of the Common Stock, as well as restricted stock units.

 

     

     

    

 

Anti-Takeover Effects of the Company’s
Charter and By-Laws

 

In addition to provisions under Delaware
law, the Company’s Charter and By-Laws contain provisions that could have the effect of discouraging potential acquisition
proposals or making a tender offer or delaying or preventing a change in control, including changes a stockholder might consider
favorable. In particular, the Charter and/or By-Laws, as applicable, among other things:

 

		●	provide the Board with the exclusive authority to call special meetings of the stockholders;

 

		●	provide the Board with the ability to alter the By-Laws without stockholder approval;

 

		●	provide the Board with the exclusive authority to fix the number of directors constituting the
whole Board; and

 

		●	provide that vacancies on the Board may be filled by a majority of directors in office, although
less than a quorum.

 

Such provisions may have the effect of
discouraging a third-party from acquiring the Company, even if doing so would be beneficial to the Company’s stockholders.
These provisions are intended to enhance the likelihood of continuity and stability in the composition of the Board and in its
policies, and to discourage some types of transactions that may involve an actual or threatened change in control of the Company.
These provisions are designed to reduce the Company’s vulnerability to an unsolicited acquisition proposal and to discourage
some tactics that may be used in proxy fights. The Company believes that the benefits of increased protection of its potential
ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure the Company outweigh
the disadvantages of discouraging such proposals because, among other things, negotiation of such proposals could result in an
improvement of their terms. However, these provisions could have the effect of discouraging others from making tender offers for
shares of the Company’s Common Stock and, as a consequence, they also may inhibit fluctuations in the market price of the
shares of the Company’s Common Stock that could result from actual or rumored takeover attempts. These provisions also may
have the effect of preventing changes in the Company’s management.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00317-of-00352.parquet"}]]